The document discusses key concepts related to good laboratory practices including Good Manufacturing Practice (GLP), Good Laboratory Practice (GLP), the US FDA rules for GLP, OECD Guidelines for the Testing of Chemicals, ISO 9000 quality management standards, total quality management (TQM), quality review and documentation, validations, and process validation. GLP and ISO 9000 establish standards and guidelines to ensure uniformity, consistency, reliability, and quality in laboratory studies and testing. The US FDA and OECD provide specific rules and guidelines for GLP compliance. Validations are required to demonstrate equipment, facilities, and processes operate as intended to maintain compliance.
Pharmaceutical industrial management covers topics like quality assurance, quality control, good manufacturing practices, good laboratory practices, and total quality management. Quality assurance aims to prevent defects and ensure products meet requirements, while quality control detects defects. Good practices provide guidelines for manufacturers to consistently produce high quality and safe products. Process and analytical method validation are important to demonstrate that procedures are suitable and reliable for their intended purposes. Documentation and change control are also important parts of pharmaceutical quality systems.
1. QUALITY ASSURANCE AND QUALITY MANAGEMENT CONCEPTS.pptxPratikTerse3
This document discusses concepts related to quality assurance and quality management. It defines quality, quality assurance, and quality control. Quality assurance aims to provide confidence that products will meet requirements, while quality control tests products to ensure they meet specifications. The key difference is that quality assurance focuses on preventing defects through processes, while quality control identifies defects through testing. Good manufacturing practices and regulatory bodies that ensure quality are also outlined.
USFDA guidelines on process validation a life cycle approachRx Ayush Sharma
The document summarizes the US FDA's 2011 guidance on process validation, which outlines a lifecycle approach. It discusses the three stages of process validation according to the guidance: (1) Process Design which defines the commercial process based on development, (2) Process Qualification which evaluates the process's capability for commercial manufacturing, and (3) Continued Process Verification which gains ongoing assurance that the process remains in control during routine production. The lifecycle approach integrates validation strategies from previous guidelines and emphasizes continual process improvement, understanding sources of variation, and controlling variation to ensure consistent quality.
Quality & compliance excellence in pharmaceuticalsAnvita Bharati
Quality can be defined in several ways including conformance to specifications, fitness for use, and value for price paid. It is judged based on factors like performance, reliability, and support services provided. Pharmaceutical products have higher quality standards and more regulations compared to consumer goods due to their intended use and potential risks. Ensuring compliance with various quality guidelines is important for patient safety and involves establishing quality systems, policies, procedures, documentation, and ongoing assessments like audits and corrective actions. Non-compliance can result in issues like complaints, recalls, and regulatory actions.
WHO Good Manufacturing Practice Requirements
Good Manufacturing Practice is the part of quality assurance that ensures that products are consistently manufactured and controlled to the quality standards appropriate to their intended use.
The document discusses various concepts related to quality including definitions of quality, quality management, quality control, quality assurance, ISO standards, total quality management, and documentation requirements. It provides definitions for quality as fitness for use, conformance to specifications, and meeting customer expectations. Quality management involves building quality into products through controls and preventing deficiencies. Quality control tests and inspects materials and products, while quality assurance reviews quality systems and procedures. Documentation is essential for defining and controlling quality systems.
Good laboratory practices in a pharmaceutical lab 1Sabahat Ali
This document discusses good laboratory practices in a pharmaceutical lab. It outlines the members of a group project on this topic and provides an introduction to pharmaceutical lab testing. It then covers topics like GMP, GLP, quality control, quality assurance, reducing human errors, and the scope of QA and QC in a pharmaceutical lab. Key points include that pharmaceutical labs test raw materials, finished products, and conduct validation, stability, and analytical method development testing. GMP and GLP aim to minimize risks and ensure consistent quality production. QA and QC work to guarantee drug quality and safety at all stages from development to sales.
Quality assurance is a wide-ranging concept covering all matters that individually or collectively influence the quality of a product. It aims to ensure that pharmaceutical products are of the quality required for their intended use. Key aspects of quality assurance include providing evidence that quality activities are being performed effectively, ensuring products meet given quality requirements, and initiating actions to dispose of non-conforming products. Quality assurance plays an important role in industries like pharmaceuticals where human safety is critical.
Pharmaceutical industrial management covers topics like quality assurance, quality control, good manufacturing practices, good laboratory practices, and total quality management. Quality assurance aims to prevent defects and ensure products meet requirements, while quality control detects defects. Good practices provide guidelines for manufacturers to consistently produce high quality and safe products. Process and analytical method validation are important to demonstrate that procedures are suitable and reliable for their intended purposes. Documentation and change control are also important parts of pharmaceutical quality systems.
1. QUALITY ASSURANCE AND QUALITY MANAGEMENT CONCEPTS.pptxPratikTerse3
This document discusses concepts related to quality assurance and quality management. It defines quality, quality assurance, and quality control. Quality assurance aims to provide confidence that products will meet requirements, while quality control tests products to ensure they meet specifications. The key difference is that quality assurance focuses on preventing defects through processes, while quality control identifies defects through testing. Good manufacturing practices and regulatory bodies that ensure quality are also outlined.
USFDA guidelines on process validation a life cycle approachRx Ayush Sharma
The document summarizes the US FDA's 2011 guidance on process validation, which outlines a lifecycle approach. It discusses the three stages of process validation according to the guidance: (1) Process Design which defines the commercial process based on development, (2) Process Qualification which evaluates the process's capability for commercial manufacturing, and (3) Continued Process Verification which gains ongoing assurance that the process remains in control during routine production. The lifecycle approach integrates validation strategies from previous guidelines and emphasizes continual process improvement, understanding sources of variation, and controlling variation to ensure consistent quality.
Quality & compliance excellence in pharmaceuticalsAnvita Bharati
Quality can be defined in several ways including conformance to specifications, fitness for use, and value for price paid. It is judged based on factors like performance, reliability, and support services provided. Pharmaceutical products have higher quality standards and more regulations compared to consumer goods due to their intended use and potential risks. Ensuring compliance with various quality guidelines is important for patient safety and involves establishing quality systems, policies, procedures, documentation, and ongoing assessments like audits and corrective actions. Non-compliance can result in issues like complaints, recalls, and regulatory actions.
WHO Good Manufacturing Practice Requirements
Good Manufacturing Practice is the part of quality assurance that ensures that products are consistently manufactured and controlled to the quality standards appropriate to their intended use.
The document discusses various concepts related to quality including definitions of quality, quality management, quality control, quality assurance, ISO standards, total quality management, and documentation requirements. It provides definitions for quality as fitness for use, conformance to specifications, and meeting customer expectations. Quality management involves building quality into products through controls and preventing deficiencies. Quality control tests and inspects materials and products, while quality assurance reviews quality systems and procedures. Documentation is essential for defining and controlling quality systems.
Good laboratory practices in a pharmaceutical lab 1Sabahat Ali
This document discusses good laboratory practices in a pharmaceutical lab. It outlines the members of a group project on this topic and provides an introduction to pharmaceutical lab testing. It then covers topics like GMP, GLP, quality control, quality assurance, reducing human errors, and the scope of QA and QC in a pharmaceutical lab. Key points include that pharmaceutical labs test raw materials, finished products, and conduct validation, stability, and analytical method development testing. GMP and GLP aim to minimize risks and ensure consistent quality production. QA and QC work to guarantee drug quality and safety at all stages from development to sales.
Quality assurance is a wide-ranging concept covering all matters that individually or collectively influence the quality of a product. It aims to ensure that pharmaceutical products are of the quality required for their intended use. Key aspects of quality assurance include providing evidence that quality activities are being performed effectively, ensuring products meet given quality requirements, and initiating actions to dispose of non-conforming products. Quality assurance plays an important role in industries like pharmaceuticals where human safety is critical.
Validation is the process of documenting that a specific process, method, or system consistently produces results meeting predetermined specifications and quality attributes. It is important for ensuring regulatory compliance and product quality. Validation involves qualification of equipment, facilities, analytical methods, and processes.
For equipment validation, there are key phases - design qualification, installation qualification, operational qualification, and performance qualification - to demonstrate the equipment is suitable for its intended purposes. Process validation also involves defining critical process parameters, in-process testing, and method validation to control quality. Proper validation helps reduce issues and ensure consistent manufacturing of products meeting quality standards.
This document discusses validation in the pharmaceutical industry. It begins by defining validation as documented evidence that a process will consistently produce products meeting specifications. It then discusses the scope of validation, including selection of raw materials, product and process design, quality control parameters, and validation of related systems. Stakeholders in validation like R&D, engineering, and quality assurance are identified. Types of validation like analytical method validation, process validation, cleaning validation, and equipment validation are also summarized.
This document discusses quality control, quality assurance, and validation processes in pharmaceutical manufacturing. It defines key terms like QA, QC, cGMP, and describes the three stages of process validation. Quality systems help ensure safety and effectiveness through management responsibilities, resources, manufacturing operations, and evaluation activities. Adhering to cGMP regulations and maintaining a robust quality system leads to consistent production of quality products.
GOOD LABORATORY PRACTICE by ILyas Mphil student.pptxAtaUrRahman50751
This document discusses Good Laboratory Practice (GLP) guidelines. It was prepared by Ilyas Ahamd and Siyar Khan, who are M.Phil scholars. GLP provides a framework for planning, conducting, monitoring, recording, reporting and archiving laboratory studies to ensure the safety of users, consumers and the environment. Key aspects of GLP include qualified personnel, validated equipment and methods, standard operating procedures, accurate documentation and record keeping, quality assurance programs, and facility organization and management. GLP aims to ensure data integrity and that results submitted to regulatory agencies accurately reflect what was found in studies.
This ppt consists of types of FDA inspection, and how to prepare for FDA inspection of pharmaceutical mfg site, and what to do before FDA inspection, During FDA inspection, and after FDA inspection.
A brief introduction of validation concept, its scope, advantage. Types of validation, stages of validation, Consideration in principle of validation. Prerequisites of validation, validation protocol, process validation, strategy of process validation of solid dosage form, validation report.
Analytical method validation.
This document provides information about quality management systems for laboratories. It discusses key aspects of a quality management system including defining quality, the importance of a QMS for ensuring reliable lab operations, and the benefits of implementing a QMS such as improved efficiency and compliance. It also outlines the 12 essential elements of an ISO-compliant lab QMS and provides details on ISO 15189, which provides standards for quality in medical laboratories.
This document summarizes ISO 13485:2016, which outlines requirements for quality management systems for organizations involved in the design, development, manufacturing, installation, or servicing of medical devices. It contains 8 clauses that address the scope, documentation requirements, management responsibilities, and other criteria for quality management processes. Organizations that meet the ISO 13485 standard can receive certification to demonstrate their commitment to quality in the medical device industry.
The document discusses strategies for assuring the quality of laboratory results. It covers quality assurance procedures such as quality control, quality assessment, laboratory standardization, and method validation. The key components of quality assurance include quality control, which uses techniques like analysis of reference materials and proficiency testing. Quality assessment involves periodic external evaluation to monitor and improve laboratory performance. Together, effective quality control and assessment help laboratories consistently produce accurate and reliable test results.
GMP aims to ensure quality, safety and efficacy of medicines by requiring manufacturers to follow quality standards and comply with marketing authorizations. Inspections verify compliance and identify any deviations between dossiers and actual practices. Quality assurance, GMP, quality control, and quality risk management are interrelated aspects of quality management that are important for producing pharmaceuticals to the required standards.
The document discusses GMP compliance audits. It defines GMP audits as a process to verify that manufacturers follow good manufacturing practices regulations. There are two types of audits - onsite audits, which involve visiting the production site, and desktop audits, which review documentation without a site visit. Audits check various aspects of production including personnel, facilities, equipment, processes, warehousing and more. They help identify issues, ensure proper controls, and improve compliance.
Validation is a key process for ensuring quality in the pharmaceutical industry. It involves establishing documented evidence that a specific process or equipment will consistently produce a product meeting predetermined specifications. There are three main phases of validation: installation qualification, operational qualification, and performance qualification which are used to demonstrate a process can repeatedly produce the desired product results. Analytical method validation also plays an important role in demonstrating test methods are suitable for their intended use in supporting drug identity, strength, quality and purity. Proper documentation and management of calibration processes are important aspects of validation.
This document provides an overview of quality management systems, including quality assurance, quality control, and good manufacturing practices (GMP). It defines quality management as determining and implementing quality policy through an organizational structure with procedures, processes, and resources. Quality assurance aims to maximize the probability of continuously producing high quality products through policies, standards, and quality checks of materials and services. Quality control refers to measuring products against standards and rectifying any differences found. Both quality assurance and quality control follow SOPs and GMP regulations to ensure pure, effective, safe products. GMP guidelines provide assurance of identity, quality, and strength of pharmaceuticals through correct manufacturing procedures.
Role of quality systems and audits in pharmaceutical manufacturing environmentMalay Pandya
By regulation, appropriate practice, and common sense, quality assurance (QA) is a critical function in the pharmaceutical manufacturing environment. The need for an independent unit to audit and comment on the appropriate application of standard operating procedures, master batch records, procedures approved in product applications, and the proper functioning of the quality control (QC) unit is paramount.
This helps assure that products are manufactured reliably, with adherence to approved specifications, and that current good manufacturing practices (cGMP) are maintained in conformance to regulation, both in the facility in general and the microenvironment of each product ’s manufacturing sequence.
This document provides an introduction to pharmaceutical validation, including its scope and merits. It defines validation according to regulatory bodies as establishing evidence that a process will consistently produce a product meeting specifications. Validation is required by cGMP and aims to produce uniform, reproducible products to reduce costs and ensure quality. It involves qualification, process, analytical, cleaning, and other types of validation performed by cross-functional teams and documented in protocols and procedures. The scope of validation is wide, while its merits include increased process knowledge, repeatability, production fluency and decreased risks and expenses.
Introduction types, Objectives, Management of audit, Responsibilities, Planni...Kunal10679
Audit and regulatory Compliance M.pharmacy Quality Assurance department Sem. 2 Introduction types, Objectives, Management of audit, Responsibilities, Planning Process, Information Gathering, Classifications of Deficiencies of auditing
This document discusses Total Quality Management (TQM) in the pharmaceutical industry. TQM is a multifaceted approach that involves building quality into every step of the pharmaceutical process from research and development to manufacturing to marketing. It utilizes various quality management techniques like quality risk management, quality by design, good manufacturing practices, and ISO standards. TQM ensures quality is maintained through all stages of production from raw materials to finished drugs. It is important for the pharmaceutical industry given many drugs are life saving and quality defects could pose health hazards.
The document discusses various types of quality assurance (QA) audits, including internal and external audits. It notes that the most common types of audits in the food industry are for product manufacturing, plant sanitation/GMP, product quality, and HACCP. Special audits may also be conducted on areas like QC programs, temperature controls, or batching practices. QA documentation includes standard operating procedures (SOPs), a quality manual, and other documents describing manufacturing and quality processes. Sanitation standard operating procedures (SSOPs) provide step-by-step instructions for cleaning areas and equipment in a food plant.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Validation is the process of documenting that a specific process, method, or system consistently produces results meeting predetermined specifications and quality attributes. It is important for ensuring regulatory compliance and product quality. Validation involves qualification of equipment, facilities, analytical methods, and processes.
For equipment validation, there are key phases - design qualification, installation qualification, operational qualification, and performance qualification - to demonstrate the equipment is suitable for its intended purposes. Process validation also involves defining critical process parameters, in-process testing, and method validation to control quality. Proper validation helps reduce issues and ensure consistent manufacturing of products meeting quality standards.
This document discusses validation in the pharmaceutical industry. It begins by defining validation as documented evidence that a process will consistently produce products meeting specifications. It then discusses the scope of validation, including selection of raw materials, product and process design, quality control parameters, and validation of related systems. Stakeholders in validation like R&D, engineering, and quality assurance are identified. Types of validation like analytical method validation, process validation, cleaning validation, and equipment validation are also summarized.
This document discusses quality control, quality assurance, and validation processes in pharmaceutical manufacturing. It defines key terms like QA, QC, cGMP, and describes the three stages of process validation. Quality systems help ensure safety and effectiveness through management responsibilities, resources, manufacturing operations, and evaluation activities. Adhering to cGMP regulations and maintaining a robust quality system leads to consistent production of quality products.
GOOD LABORATORY PRACTICE by ILyas Mphil student.pptxAtaUrRahman50751
This document discusses Good Laboratory Practice (GLP) guidelines. It was prepared by Ilyas Ahamd and Siyar Khan, who are M.Phil scholars. GLP provides a framework for planning, conducting, monitoring, recording, reporting and archiving laboratory studies to ensure the safety of users, consumers and the environment. Key aspects of GLP include qualified personnel, validated equipment and methods, standard operating procedures, accurate documentation and record keeping, quality assurance programs, and facility organization and management. GLP aims to ensure data integrity and that results submitted to regulatory agencies accurately reflect what was found in studies.
This ppt consists of types of FDA inspection, and how to prepare for FDA inspection of pharmaceutical mfg site, and what to do before FDA inspection, During FDA inspection, and after FDA inspection.
A brief introduction of validation concept, its scope, advantage. Types of validation, stages of validation, Consideration in principle of validation. Prerequisites of validation, validation protocol, process validation, strategy of process validation of solid dosage form, validation report.
Analytical method validation.
This document provides information about quality management systems for laboratories. It discusses key aspects of a quality management system including defining quality, the importance of a QMS for ensuring reliable lab operations, and the benefits of implementing a QMS such as improved efficiency and compliance. It also outlines the 12 essential elements of an ISO-compliant lab QMS and provides details on ISO 15189, which provides standards for quality in medical laboratories.
This document summarizes ISO 13485:2016, which outlines requirements for quality management systems for organizations involved in the design, development, manufacturing, installation, or servicing of medical devices. It contains 8 clauses that address the scope, documentation requirements, management responsibilities, and other criteria for quality management processes. Organizations that meet the ISO 13485 standard can receive certification to demonstrate their commitment to quality in the medical device industry.
The document discusses strategies for assuring the quality of laboratory results. It covers quality assurance procedures such as quality control, quality assessment, laboratory standardization, and method validation. The key components of quality assurance include quality control, which uses techniques like analysis of reference materials and proficiency testing. Quality assessment involves periodic external evaluation to monitor and improve laboratory performance. Together, effective quality control and assessment help laboratories consistently produce accurate and reliable test results.
GMP aims to ensure quality, safety and efficacy of medicines by requiring manufacturers to follow quality standards and comply with marketing authorizations. Inspections verify compliance and identify any deviations between dossiers and actual practices. Quality assurance, GMP, quality control, and quality risk management are interrelated aspects of quality management that are important for producing pharmaceuticals to the required standards.
The document discusses GMP compliance audits. It defines GMP audits as a process to verify that manufacturers follow good manufacturing practices regulations. There are two types of audits - onsite audits, which involve visiting the production site, and desktop audits, which review documentation without a site visit. Audits check various aspects of production including personnel, facilities, equipment, processes, warehousing and more. They help identify issues, ensure proper controls, and improve compliance.
Validation is a key process for ensuring quality in the pharmaceutical industry. It involves establishing documented evidence that a specific process or equipment will consistently produce a product meeting predetermined specifications. There are three main phases of validation: installation qualification, operational qualification, and performance qualification which are used to demonstrate a process can repeatedly produce the desired product results. Analytical method validation also plays an important role in demonstrating test methods are suitable for their intended use in supporting drug identity, strength, quality and purity. Proper documentation and management of calibration processes are important aspects of validation.
This document provides an overview of quality management systems, including quality assurance, quality control, and good manufacturing practices (GMP). It defines quality management as determining and implementing quality policy through an organizational structure with procedures, processes, and resources. Quality assurance aims to maximize the probability of continuously producing high quality products through policies, standards, and quality checks of materials and services. Quality control refers to measuring products against standards and rectifying any differences found. Both quality assurance and quality control follow SOPs and GMP regulations to ensure pure, effective, safe products. GMP guidelines provide assurance of identity, quality, and strength of pharmaceuticals through correct manufacturing procedures.
Role of quality systems and audits in pharmaceutical manufacturing environmentMalay Pandya
By regulation, appropriate practice, and common sense, quality assurance (QA) is a critical function in the pharmaceutical manufacturing environment. The need for an independent unit to audit and comment on the appropriate application of standard operating procedures, master batch records, procedures approved in product applications, and the proper functioning of the quality control (QC) unit is paramount.
This helps assure that products are manufactured reliably, with adherence to approved specifications, and that current good manufacturing practices (cGMP) are maintained in conformance to regulation, both in the facility in general and the microenvironment of each product ’s manufacturing sequence.
This document provides an introduction to pharmaceutical validation, including its scope and merits. It defines validation according to regulatory bodies as establishing evidence that a process will consistently produce a product meeting specifications. Validation is required by cGMP and aims to produce uniform, reproducible products to reduce costs and ensure quality. It involves qualification, process, analytical, cleaning, and other types of validation performed by cross-functional teams and documented in protocols and procedures. The scope of validation is wide, while its merits include increased process knowledge, repeatability, production fluency and decreased risks and expenses.
Introduction types, Objectives, Management of audit, Responsibilities, Planni...Kunal10679
Audit and regulatory Compliance M.pharmacy Quality Assurance department Sem. 2 Introduction types, Objectives, Management of audit, Responsibilities, Planning Process, Information Gathering, Classifications of Deficiencies of auditing
This document discusses Total Quality Management (TQM) in the pharmaceutical industry. TQM is a multifaceted approach that involves building quality into every step of the pharmaceutical process from research and development to manufacturing to marketing. It utilizes various quality management techniques like quality risk management, quality by design, good manufacturing practices, and ISO standards. TQM ensures quality is maintained through all stages of production from raw materials to finished drugs. It is important for the pharmaceutical industry given many drugs are life saving and quality defects could pose health hazards.
The document discusses various types of quality assurance (QA) audits, including internal and external audits. It notes that the most common types of audits in the food industry are for product manufacturing, plant sanitation/GMP, product quality, and HACCP. Special audits may also be conducted on areas like QC programs, temperature controls, or batching practices. QA documentation includes standard operating procedures (SOPs), a quality manual, and other documents describing manufacturing and quality processes. Sanitation standard operating procedures (SSOPs) provide step-by-step instructions for cleaning areas and equipment in a food plant.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...Donc Test
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Study Guide Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Course Hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Answers Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Course hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Study Guide Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Ebook Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Questions Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Stuvia
2. • In the experimental research area, Good Manufacturing
Practice or GLP refers to a quality system.
It ensures uniformity, consistency, reliability, reproducibility,
quality, and integrity of chemical non-clinical safety tests;
from physio-chemical properties through acute to chronic
toxicity tests.
GLP was first introduced in New Zealand and Denmark in
1972 and
In the US in 1978, due to the industrial Bio-Test Labs scandal.
GLP applies to non-clinical studies conducted for the
assessment of the safety or efficacy of chemicals to man,
animals, and the environment.
3. • Good Laboratory Practice embodies a set of principles that provides a
framework within which laboratory studies are planned, performed,
monitored, recorded, reported, and archived.
• These studies were undertaken to generate data by which the hazards and
risks to users, consumers, and third parties, including the environment, can be
assessed for pharmaceuticals (only preclinical studies), agrochemicals,
cosmetics, food additives, feed additives, and contaminants, novel food,
biocides, detergents, etc…..
• GLP helps assure regulatory authorities that the data submitted are a true
reflection of the results obtained during the study and can therefore be relied
upon when making risks/safety assessments.
• GLP is a data quality system so should not be confused with standards for
laboratory safety-appropriate
4. THE US FDA
• In the US FDA has rules for GLP in 21CFR58.
• Preclinical trials on animals in the United States of
America use their rules before clinical research on
humans.
• Research in the US not conducted under these
restrictions or research done outside the US not
conducted according to the OECD Guidelines might
be inadmissible in support of a New Drug
Application in the US.
5. OECD GUIDELINES FOR THE TESTING
OF CHEMICALS
• They were first published in 1981, and they are split
into five sections:
1. Section 1: Physical-chemical Properties
2. Section 2: Effects on the Biotic System
3. Section 3: Degradation and Accumulation
4. Section 4: Health Effects
5. Section 5: Other Test Guidelines
• Guidelines are numbered with three-digit numbers
• Section number is the first number
• Sometimes guidelines are suffixed with a letter.
6. ISO 9000
• The ISO 9000 (International Organization for Standardization 9000) family of
quality management system standards is designed to help organizations
ensure that they meet the needs of customers and other stakeholders
while meeting statutory and regulatory requirements related to the
product.
• The ISO 9000 deals with the fundamentals of the quality management
system
• ISO 9001 deals with the requirements that organizations wishing to meet
the standards must fulfil.
7. • ISO 9000 is headquartered in Geneva, Switzerland.
• Over one million organizations worldwide are
independently certified to meet the requirement of
ISO 9001
• ISO 9000 was first published in 9187 and based on the
BS 5750 series of standards from BSI (British
Standards Institution)
8. ISO 9000 SERIES QUALITY
MANAGEMENT PRINCIPLES
• ISO 9000 series based on eight quality management
principles
• The eight quality management principles are defined
in ISO 9000:200 Quality Management System-
Fundamental and Vocabulary
• ISO 9004:2009, Managing for the sustained success of
an organization- a quality management approach
9. • Principle 1 customer focus: Organizations depend on their customers and therefore
should understand current and future customers’ needs
• Principle 2 Leadership: leaders establish the unity of purpose and direction of the
organization
• Principle 3 Involvement of people: People of all levels are the essence of an
organization and their full involvement enables their abilities to be used for the
organization’s benefit
• Principle 4 Process approach: The desired results are achieved more efficiently when
activities and related resources are managed as a process.
• Principle 5 System approach to management: Identifying, understanding, and
managing interrelated processes as a system contributes to the organization’s
effectiveness and efficiency in achieving its objectives
• Principle 6 Continual improvement: continual improvement of the organization’s
overall performance should be a permanent objective
•
10. • Principle 7 Factual approach to decision-making
• Principle 8 Mutually beneficial supplier relationships: an organization and its suppliers
are interdependent and a mutually beneficial relationship enhances the ability of
both to create value.
11. TQM TOTAL QUALITY MANAGEMENT
• It is consists of organization
• It need wide effects to install and make permanent a
climate in which an organizations continuously
improves its ability to deliver high
• TQM efforts typically draw heavily on the previously
develop tools and techniques of quality control
12. QUALITY REVIEW AND QUALITY
DOCUMENTATION
1. Regulatory control
contain three regulatory classes
The regulatory control for each device class include:
I. General control(low to moderate risk)
II. General control and special control(moderate to high risk)
III. General control and premarket approval(high risk)
13. 2. General controls
general control is described in the following sections of the FD &C Act
501: Adulterated device
502: Misbranded device
510: Registration of producer of device
- establishment and registration and device listing
- premarket notification
- reprocessed single
516: Banned devices
518: Notification and other remedies
- notifications
- repair
- replacement
- refund
- reimbursement
- mandatory recall
519: Records and report device
- adverse event report
14. PHARMACEUTICAL ANALYSIS
• device tracking
• unique device identification system
• Reports of removal and corrections
520: general provisions respecting the control of devices intended
for human use
• custom device
• Restricted device
• Good manufacturing practice requirement
• Exemptions for devices for investigational use
• Transitional provisions for devices considered as new drugs
• Humanitarian device exemption
15. SPECIAL CONTROLS
• Special controls required forclass 2 devices
• performance standards
• postmarked surveillance
• Patient registries
• Special labeling requirements
• Premarket data requirement
• Guidelines
16. PREMARKET APPROVAL
• Under federal law class 3 devices are subject to the approval of premarket approval
application (PMA)devices
• Device that are not within a type marketed before the date of the Medical Device
Amendments of 1976 referred to preamendments devices
• Class 3 are automatically comes under federal law
• The FDA classified into class 3 devices intended to used in supporting or sustaining human
life or preventing impairment of human health
17. VALIDATIONS
• For medical device, food, blood products, biological product , tissue , establishment, clinical trials
conducting institutions we use the validation
• Validation is a process of establishing documentary evidence demonstrating that a procedure,
process, or activity carried out in production or testing maintains the desired level of compliance at
all stages.
• Validation required of food and drug, pharmaceutical regulating agencies like FDA’s good
manufacturing practices guidelines
• Subsections used in the validation:
1. Equipment validation
2. Facilities validation
3. HVAC system validation
4. Cleaning validation
5. Process validation
6. Analytical validation
7. Computer system validation
8. Packaging validation
18. THE VALIDATION PROCESS
• The validation scope , boundaries and responsibilities for each process or group of similar
processes or similar equipment's must be documented and approved in a validation plan.
• These documents, terms and reference for the protocol authors are for use in setting the scope of
their protocols. It must be based on a Validation Risk Assessment(VRA) to ensure that the scope
of validation being authorized is appropriate for the complexity and importance of the equipment
or process under validation
• The reference is that may affect the efficacy, quality and or records of the product are properly
qualified.
19. • Qualification includes the following steps:
• Design qualification(DQ)- demonstrates that the proposed design will satisfy all the
requirements that are defined and defined and detailed in the User Requirement
Specification(URS) satisfactory execution of the DQ is a mandatory requirement
before construction of the new design can be authorized.
• Installation qualification(IQ)- demonstrate that the process or equipment meets all
specification, is installed correctly, and all requirement components and
documentation needed for continued operation are installed and in place.
• Operational qualification(OQ)- demonstrates that all facets of the process or
equipment are operating correctly. Performance qualification(PQ)- demonstrate that
the process or equipment performs as intended in a consistent manner over time
• Component qualification(CQ)- is a relatively new term developed in 2005. this term
refers to the manufacturing of auxiliary components to ensure that they are
manufactured t the correct design criteria. This could include packaging components
must have some type of random inspection to ensure that the third party
manufacturer’s process is consistently producing components that are used in the
world of GMP at drug or biologic manufacturer.
20. PROCESSED VALIDATION
• Process validation is the analysis of data gathered throughout
the design and manufacturing of a product in order to confirm
that the process can reliably output products of a determined
standards.
• Regulatory authorities like EMA and FDA have published the
guidelines relating to process validation.
• The purpose of process validation is to ensure varied inputs lead
to consistent and high quality outputs
• Process validations an ongoing process that must be frequently
adapted as manufacturing feedback is gathered.
• End to end validation of process is essential in determining
product quality because quality cannot always be determined by
finished product inspection
• Process validation can be broken down into 3 steps: process
design, process qualification, and continued process verifications
21. VALIDATION OF EQUIPMENT
• Validation first developed for equipment and process.
• In 1993 the software for a large-radiotherapy device
was not designed and tested properly.
• Several problems resulted in several devices giving
doses of radiation higher than intended
• So many patients died and several got permanently
injured that is why validation of equipment is
required for pharma Industry following are the steps
followed to do validation of equipment in SAP and
how create link between maintenance Order and
calibration order.